Monica Checcarelli
About Monica Checcarelli
Monica Checcarelli is a Grant Analyst at Bristol-Myers Squibb with over 30 years of experience in various roles within the company.
Current Role at Bristol-Myers Squibb
Monica Checcarelli currently holds the position of Grant Analyst at Bristol-Myers Squibb in Roma, Italia. She started this role in April 2019. Alongside this role, she also serves as the Oncology Business Unit Director Assistant. Her responsibilities likely involve overseeing grant applications, ensuring compliance with funding requirements, and supporting the Oncology Business Unit Director with various administrative tasks.
Professional Experience in Immuno-Oncology
Monica served as the Immuno-Oncology Business Unit Assistant at Bristol-Myers Squibb from 2015 to 2016 for a duration of one year in Roma, Italia. In this role, she was responsible for supporting the business unit's administrative and operational activities, contributing to the coordination of immuno-oncology projects, and facilitating communication within the division.
Role as Onco-Hematology Business Unit Assistant
Monica worked as the Onco-Hematology Business Unit Assistant at Bristol-Myers Squibb between 2011 and 2015, covering a period of four years. She played a crucial role in supporting the onco-hematology division, managing administrative tasks, and aiding in the coordination and execution of business unit strategies and operations.
Experience in Neuroscience
From 2010 to 2011, Monica held the position of Neuroscience Business Unit Assistant at Bristol-Myers Squibb for one year. Her responsibilities included supporting the business unit's administrative functions, assisting in the coordination of neuroscience projects, and providing essential support to the team.
Management of 'The National Monitoring Center for Clinical Trials'
Between 2003 and 2007, Monica managed 'The National Monitoring Center for Clinical Trials' (Osservatorio AIFA) at Bristol-Myers Squibb for a period of four years. In this role, she oversaw the operations of the monitoring center, ensuring adherence to clinical trial regulations and contributing to the efficient management of clinical trial activities.